½ÃÀ庸°í¼­
»óǰÄÚµå
1261199

¼¼°èÀÇ ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°, ¼ö¼ú À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2022-2029³â)

Global Minimally Invasive Neurosurgical Devices Market Size study & Forecast, by Product, by Surgery Type, by End-Use and Regional Analysis, 2022-2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³ú½Å°æ¿Ü°ú¿¡ »ç¿ëµÇ´Â ÃÖ¼Òħ½À ¼ö¼ú¿ë ±â±âÀÔ´Ï´Ù.

ÀÌ ±â±¸¸¦ »ç¿ëÇϸé Ä¡À¯±îÁöÀÇ ½Ã°£ÀÌ ´ÜÃàµÇ°í ÇÊ¿äÇÑ Àý°³ÀÇ Å©±â°¡ Á¦Çѵ˴ϴÙ. ÀÌ ±â±¸´Â ³ú½Å°æ ¼ö¼ú Àü¹®ÀÇ¿¡ ÀÇÇØ ÀÚÁÖ ¸¸µé¾îÁö°í »ç¿ëµÇ¸ç ÀϹÝÀûÀ¸·Î ¸Å¿ì Á¤¹ÐÇÑ ¼ö¼úÀ» À§ÇØ »ó´ëÀûÀ¸·Î ÀÛ½À´Ï´Ù. ÃÖ¼Òħ½À ³ú ¼ö¼ú Àåºñ´Â µ¿ÀÏÇÑ ¸ñÀûÀ¸·Î »ç¿ëµÇ´Â °³º¹ ¼ö¼úº¸´Ù ¿Ü»óÀÌ ÀûÀº ¹æ¹ýÀ¸·Î ¼ö¼úÀ» ÀçÁ¤ÀÇÇÕ´Ï´Ù. ¸¶ÀÌÅ©·Î½ºÄÚÇÁ ¹× ³»½Ã°æ ±Ô¸ð·Î ¼ö¼ú Çʵ带 Æò°¡ÇÏ´Â ÃÖ¼Òħ½À ³ú½Å°æ ¼ö¼ú(MIS)Àº º¹°­°æ ÀåÄ¡ ¹× ¼ö¼ú ±â±¸ÀÇ ¿ø°Ý Á¦¾î¸¦ ÀÏ»óÀûÀ¸·Î »ç¿ëÇÕ´Ï´Ù. ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ³ë³â Àα¸ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¼¼°è Àα¸°¡ °í·ÉÈ­µÇ°í ´õ ¸¹Àº ½Å°æ ÁúȯÀÌ Áø´ÜµÊ¿¡ µû¶ó ÀÌ·¯ÇÑ Áúº´À¸·Î ÀÎÇÑ »ç¸Á·ü°ú Àå¾Ö ºñ¿ëÀº Àü¼¼°è °øÁß º¸°Ç¿¡ ´ëÇÑ ¿ì·Á·Î Á¡Á¡ Àνĵǰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î -¹ü¹Ìº¸°Ç±â±¸(PAHO)¿¡ µû¸£¸é -2019³â ½Å°æÁúȯÀ¸·Î »ç¸ÁÇÑ »ç¶÷Àº 533,172¸íÀ» Â÷ÁöÇß°í, 320,043¸í(60%)ÀÌ ¿©¼º, 213,129¸í(40%)ÀÌ ³²¼ºÀ̾ú½À´Ï´Ù. ¿¬·ÉÇ¥ÁØÈ­ »ç¸Á·üÀº Àα¸ 10¸¸¸í´ç 32.9¸í, ³²¼ºÀº 33.1¸í, ¿©¼ºÀº 32.2¸íÀ̾ú½À´Ï´Ù. ¿¬·É Ç¥ÁØÈ­ »ç¸Á·üÀÌ °¡Àå ³ôÀº °ÍÀº ¹Ì±¹(Àα¸ 10¸¸¸í´ç 47.4¸í)À̰í, °¡Àå ³·Àº °ÍÀº º£³×¼ö¿¤¶ó(Àα¸ 10¸¸¸í´ç 6.6¸í)ÀÔ´Ï´Ù. ¶ÇÇÑ ¼¼°èÀºÇà±×·ì¿¡ µû¸£¸é ¼¼°è ³ëÀÎ Àα¸´Â 2020³â 7¾ï 2,700¸¸ ¸íÀ¸·Î ÇâÈÄ 30³â ¸¸¿¡ 3¹è°¡ µÇ°í 2050³â¿¡´Â 15¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, Ç÷°üÀå¾ÖÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÏ°í ½Å°æ¿Ü°ú ¼ö¼úÀÇ ¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡, ¿¹Ãø±â°£ µ¿¾È ½ÃÀåÀº À¯¸®ÇÑ ¼ºÀå Àü¸ÁÀ» ¼¼¿ï ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÃÖ¼Ò Ä§½À¼º ½Å°æ ¼ö¼ú ¹× Ä¡·á ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ 2022³âºÎÅÍ 2029³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀÌ ÀúÇØµË´Ï´Ù.

ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì, ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« ¹× ¼¼°è ±âŸ Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ½Å°æÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡ ¿Ü¿¡µµ ½Å°æ ¿Ü°ú ÀÇ»ç¿Í ÀÇ»çµé »çÀÌ¿¡¼­ ÀÌ·¯ÇÑ ½Å°æ ÇÐÀû ÀåÄ¡ÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ¼öÀÍ Ãø¸é¿¡¼­ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¹Ý¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ Àα¸ Áõ°¡, ½Å°æ Áúȯ À¯º´·ü Áõ°¡, °Ç°­ °ü¸® ¼­ºñ½º È®´ë µîÀÇ ¿äÀÎÀ¸·Î ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®¿Í ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ¹àÈ÷°í ¾ÕÀ¸·Î ¼ö³â°£ÀÇ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» Æ÷ÂøÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ¸¶ÄÏ ½º³À¼¦
  • ¼¼°è¡¤ºÎ¹®º° ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå, Áö¿ªº°, 2019-2029³â
    • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå, Á¦Ç°º°, 2019-2029³â
    • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå, ¼ö¼ú À¯Çüº°, 2019-2029³â
    • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2029³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ °¡Á¤

Á¦2Àå ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • Á¶»ç ´ë»ó ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
  • º» Á¶»çÀÇ ´ë»óÀÌ µÈ ÇØ
  • ȯÀ² º¯È¯À²

Á¦3Àå ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå ¿ªÇÐ

  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀåÀÇ ¿µÇ⠺м®(2019-2029³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ½Å°æ°è ÁúȯÀÇ À¯º´·üÀÇ Áõ°¡
      • Áõ°¡ÇÏ´Â ³ë³â Àα¸
    • ½ÃÀåÀÇ °úÁ¦
      • ³ú½Å°æ¿Ü°ú¿ë µð¹ÙÀ̽ºÀÇ °íºñ¿ëÈ­
    • ½ÃÀå ±âȸ
      • Ç÷°üÀå¾ÖÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÑ´Ù
      • ³ú½Å°æ¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡

Á¦4Àå ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù(2019-2029³â)
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • ¼Ò¼È
    • Å×Å©´ÏÄÃ
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ¾÷°è °ü°èÀÚ Àü¸Á
  • ¾Ö³Î¸®½ºÆ®ÀÇ ±Ç°í¿Í °á·Ð

Á¦5Àå À§Çè Æò°¡: COVID-19ÀÇ ¿µÇâ

  • COVID-19°¡ ¾÷°è¿¡ ¹ÌÄ¡´Â ÀüüÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ Æò°¡
  • COVID-19 ÀÌÀü°ú COVID-19 ÀÌÈÄÀÇ ½ÃÀå ½Ã³ª¸®¿À

Á¦6Àå ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ¸¶ÄÏ ½º³À¼¦
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå, ¼­ºê ºÎ¹® ºÐ¼®
    • ¼­ÁöÄà µð¹ÙÀ̽º
    • °¨½Ã¡¤°¡½ÃÈ­ ÀåÄ¡
    • ³»½Ã°æ¿ë µð¹ÙÀ̽º

Á¦7Àå ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå : ¼ö¼ú À¯Çüº°

  • ¸¶ÄÏ ½º³À¼¦
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå : ¼ö¼ú À¯Çüº°, ¼º´É-ÀáÀç´É·Â ºÐ¼®
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå ¼ö¼ú À¯Çüº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå, ¼­ºê ºÎ¹® ºÐ¼®
    • ³»½Ã°æ ³ú½Å°æ¿Ü°ú
    • µÎ°³³»
    • ôÃ߿ܰú ¼ö¼ú

Á¦8Àå ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¸¶ÄÏ ½º³À¼¦
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå, ¼­ºê ºÎ¹® ºÐ¼®
    • º´¿ø?Áø·á¼Ò
    • ÀÇ·á±â°ü
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦9Àå ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå, Áö¿ªº° ¸¶ÄÏ ½º³À¼¦
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • ¼ö¼ú À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • ij³ª´Ù
  • À¯·´ ÃÖ¼Òħ½À ³ú¿Ü°ú ¼ö¼ú ±â±â ½ÃÀå ½º³À¼¦
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå ½º³À¼¦
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÃÖ¼Òħ½À ³ú½Å°æ¿Ü°ú¿ë ±â±â ½ÃÀå ½º³À¼¦
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ¼¼°è ±âŸ Áö¿ª

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • General Medical Inc.
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¸¸)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Stryker
    • Zimmer Biomet
    • B. Braun Melsungen AG
    • Olympus Corporation
    • Renishaw Plc.
    • Medtronic
    • Danaher
    • Zeiss
    • Karl Storz SE & Co. KG

Á¦11Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • ¹ë¸®µ¥À̼Ç
    • ÃâÆÇ
  • Á¶»çÀÇ Æ¯Â¡
  • Á¶»çÀÇ °¡Á¤
ksm 23.04.28

Global Minimally Invasive Neurosurgical Devices Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Minimally invasive neurosurgical devices are those utilized in neurosurgery. With the aid of this device, healing time is quickened, and the size of the required incision is constrained. These instruments are frequently created and used by neurosurgery specialists and are normally relatively small for extremely precise surgeries. Minimally invasive neurosurgical devices are any less traumatic method than open surgery used for the same purpose, and they are redefining surgery. In minimally invasive neurosurgery (MIS) procedures, which assess the operating field on a micro- or endoscopic scale, laparoscopic equipment and remote controls for surgical tools are routinely used. The increasing prevalence of neurological disorders and growing geriatric population are key factors driving the market growth.

As the world's population ages and more neurological illnesses are diagnosed, the cost of mortality and impairment brought on by these conditions is being increasingly acknowledged as a worldwide public health concern. For instance - as per Pan American Health Organization (PAHO) - in 2019 people died because of neurological disorders accounted for 533,172, with 320,043 (60%) women and 213,129 (40%) men. Age-standardized mortality rates were 32.9 per 100,000 people, with 33.1 deaths per 100,000 people for males and 32.2 for women. The United States of America has the highest age-standardized death rate (47.4 deaths per 100,000 people), while Venezuela has the lowest rate (6.6 deaths per 100,000 population). Furthermore, according to the World Bank Group, the world's old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Also, increasing incidence of vascular disorders increases and growing number of neurosurgical procedures would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Minimally Invasive Neurosurgical Devices and procedures stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Minimally Invasive Neurosurgical Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of neurovascular diseases and also the growing awareness among neurosurgeons and doctors regarding the benefits of these neurology devices. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, increasing prevalence of neurological conditions as well as growing expansion of healthcare services in the region.

Major market players included in this report are:

  • General Medical Inc.
  • Stryker
  • Zimmer Biomet
  • B. Braun Melsungen AG
  • Olympus Corporation
  • Renishaw Plc.
  • Medtronic
  • Danaher
  • Zeiss
  • Karl Storz SE & Co. KG

Recent Developments in the Market:

  • In September 2022, Brainlab announced the acquisition of Waldkrich, Germany based Dr. Langer Medical GmbH. The family-owned company specializes in the development of intraoperative neuromonitoring solutions and related equipment for surgical interventions.

Global Minimally Invasive Neurosurgical Devices Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Surgery Type, End-Use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product

  • Surgical Devices
  • Monitoring and Visualization Devices
  • Endoscopy Devices

By Surgery Type

  • Endonasal Neurosurgery
  • Intracranial
  • Spinal Surgery

By End-Use

  • Hospital & Clinics
  • Medical Institution
  • Ambulatory Surgical Center

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Minimally Invasive Neurosurgical Devices Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Minimally Invasive Neurosurgical Devices Market, by Product, 2019-2029 (USD Million)
    • 1.2.3. Minimally Invasive Neurosurgical Devices Market, by Surgery Type, 2019-2029 (USD Million)
    • 1.2.4. Minimally Invasive Neurosurgical Devices Market, by End-Use, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Minimally Invasive Neurosurgical Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Minimally Invasive Neurosurgical Devices Market Dynamics

  • 3.1. Minimally Invasive Neurosurgical Devices Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of neurological disorders
      • 3.1.1.2. Growing Geriatric Population
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost associated with Neurosurgical Devices
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing incidence of vascular disorders increases
      • 3.1.3.2. Growing number of Neurosurgical Procedures

Chapter 4. Global Minimally Invasive Neurosurgical Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Minimally Invasive Neurosurgical Devices Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Minimally Invasive Neurosurgical Devices Market by Product, Performance - Potential Analysis
  • 6.3. Global Minimally Invasive Neurosurgical Devices Market Estimates & Forecasts by Product 2019-2029 (USD Million)
  • 6.4. Minimally Invasive Neurosurgical Devices Market, Sub Segment Analysis
    • 6.4.1. Surgical Devices
    • 6.4.2. Monitoring and Visualization Devices
    • 6.4.3. Endoscopy Devices

Chapter 7. Global Minimally Invasive Neurosurgical Devices Market, by Surgery Type

  • 7.1. Market Snapshot
  • 7.2. Global Minimally Invasive Neurosurgical Devices Market by Surgery Type, Performance - Potential Analysis
  • 7.3. Global Minimally Invasive Neurosurgical Devices Market Estimates & Forecasts by Surgery Type 2019-2029 (USD Million)
  • 7.4. Minimally Invasive Neurosurgical Devices Market, Sub Segment Analysis
    • 7.4.1. Endonasal Neurosurgery
    • 7.4.2. Intracranial
    • 7.4.3. Spinal Surgery

Chapter 8. Global Minimally Invasive Neurosurgical Devices Market, by End-Use

  • 8.1. Market Snapshot
  • 8.2. Global Minimally Invasive Neurosurgical Devices Market by End-Use, Performance - Potential Analysis
  • 8.3. Global Minimally Invasive Neurosurgical Devices Market Estimates & Forecasts by End-Use 2019-2029 (USD Million)
  • 8.4. Minimally Invasive Neurosurgical Devices Market, Sub Segment Analysis
    • 8.4.1. Hospital & Clinics
    • 8.4.2. Medical Institution
    • 8.4.3. Ambulatory Surgical Centers

Chapter 9. Global Minimally Invasive Neurosurgical Devices Market, Regional Analysis

  • 9.1. Minimally Invasive Neurosurgical Devices Market, Regional Market Snapshot
  • 9.2. North America Minimally Invasive Neurosurgical Devices Market
    • 9.2.1. U.S. Minimally Invasive Neurosurgical Devices Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Surgery Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-Use breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Minimally Invasive Neurosurgical Devices Market
  • 9.3. Europe Minimally Invasive Neurosurgical Devices Market Snapshot
    • 9.3.1. U.K. Minimally Invasive Neurosurgical Devices Market
    • 9.3.2. Germany Minimally Invasive Neurosurgical Devices Market
    • 9.3.3. France Minimally Invasive Neurosurgical Devices Market
    • 9.3.4. Spain Minimally Invasive Neurosurgical Devices Market
    • 9.3.5. Italy Minimally Invasive Neurosurgical Devices Market
    • 9.3.6. Rest of Europe Minimally Invasive Neurosurgical Devices Market
  • 9.4. Asia-Pacific Minimally Invasive Neurosurgical Devices Market Snapshot
    • 9.4.1. China Minimally Invasive Neurosurgical Devices Market
    • 9.4.2. India Minimally Invasive Neurosurgical Devices Market
    • 9.4.3. Japan Minimally Invasive Neurosurgical Devices Market
    • 9.4.4. Australia Minimally Invasive Neurosurgical Devices Market
    • 9.4.5. South Korea Minimally Invasive Neurosurgical Devices Market
    • 9.4.6. Rest of Asia Pacific Minimally Invasive Neurosurgical Devices Market
  • 9.5. Latin America Minimally Invasive Neurosurgical Devices Market Snapshot
    • 9.5.1. Brazil Minimally Invasive Neurosurgical Devices Market
    • 9.5.2. Mexico Minimally Invasive Neurosurgical Devices Market
    • 9.5.3. Rest of Latin America Minimally Invasive Neurosurgical Devices Market
  • 9.6. Rest of The World Minimally Invasive Neurosurgical Devices Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. General Medical Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Stryker
    • 10.2.3. Zimmer Biomet
    • 10.2.4. B. Braun Melsungen AG
    • 10.2.5. Olympus Corporation
    • 10.2.6. Renishaw Plc.
    • 10.2.7. Medtronic
    • 10.2.8. Danaher
    • 10.2.9. Zeiss
    • 10.2.10. Karl Storz SE & Co. KG

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦